GM-CT-01
DAVFU-007
Phase 2 small_molecule terminated
Quick answer
GM-CT-01 for Cancer of the Bile Duct is a Phase 2 program (small_molecule) at GALECTIN THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GALECTIN THERAPEUTICS INC
- Indication
- Cancer of the Bile Duct
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated